In mouse models of pancreatic ductal adenocarcinoma tumorigenesis, mutant p53 is used as a driver that induces metaplastic reprogramming of acinar cells such that mutant KRAS can subsequently cause expansion of the mutant cells. Here, KRAS is linked to pancreatic ductal adenocarcinoma.